Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 28, 2011

View Archived Issues

GlaxoSmithKline reflects on achievements of third quarter 2011

In vitro and clinical data presented on Vitae Pharmaceuticals' renin inhibitor

Bristol-Myers Squibb offers report on third quarter 2011

Mibefradil dihydrochloride given with temozolomide in murine glioma model

Lilly initiates patient recruitment in phase III study of LY-2439821

Novartis obtains approval in Japan for new indication for Sandostatin LAR

Japanese authorities approve Beselna cream for actinic keratosis

Japanese researchers identify new biomarker for diagnosis/monitoring of RA

Angiogenesis inhibitor may enhance effects of therapy with oncolytic virus

Preclinical results reported for LEE-011 in human liposarcoma

Canadian and Chinese scientists disclose new flavonoid dimers

Novel compounds for diabetes prepared by Chinese team

biOasis enters agreement with Shire Human Genetic Therapies

Novel neuropeptide S receptor antagonists presented by U.S. team

Synairgen reports preclinical results of aerosolized IFN-beta use in viral pneumonia

Hanmi applies for E.U. orphan drug designation for LAPS-rhGH

New iron complexes for cancer disclosed by IHI Corporation

New nicotinic acetylcholine alpha7 receptor ligand prodrugs disclosed by Bristol-Myers Squibb

Bausch & Lomb completes patient recruitment in BOL-303259-X study

NIH discontinues use of tenofovir gel in HIV prevention study

European Commission approves Novartis' triple combination pill for high blood pressure

Japanese authorities expand approval of Pfizer's Diflucan

NICE recommends Eliquis for prevention of VTE in hip and knee surgery

Inspiration Biopharmaceuticals begins second pivotal study of OBI-1

Regeneron and Bayer commence Chinese phase III study of Eylea

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...